Literature DB >> 3000326

Pathologic examination of ciliary body melanoma treated with proton beam irradiation.

A P Ferry, C J Blair, E S Gragoudas, S C Volk.   

Abstract

Proton beam irradiation is one of the radiotherapeutic techniques currently used to manage uveal melanomas. Although this therapeutic modality has been in use for a decade and although nearly 500 patients have been so treated, there are only two published reports of the pathologic examination of these eyes. Key features found on pathologic examination of our patient's enucleated eye included vascular alterations in the tumor's blood supply, lymphocytic infiltrates, and lipoidal degeneration of tumor cells. The interval from therapy to enucleation in our patient was much longer than in the several previously reported cases, a factor allowing for the development of a more cumulative radiation effect on the tumor. The extent and degree of radiation-induced necrosis in our patient's tumor were more profound than in previous reports.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3000326     DOI: 10.1001/archopht.1985.01050120083027

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  12 in total

Review 1.  Uveal melanoma: therapeutic consequences of doubling times and irradiation results; a review.

Authors:  W A Manschot; R van Strik
Journal:  Int Ophthalmol       Date:  1992-03       Impact factor: 2.031

2.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

3.  Histological study of choroidal malignant melanoma treated by carbon ion radiotherapy.

Authors:  Masatoshi Tsuji; Katsuaki Kimura; Hiroshi Tsuji; Masamichi Goto; Hiroshi Yoshikawa; Taiji Sakamoto
Journal:  Jpn J Ophthalmol       Date:  2007-04-06       Impact factor: 2.447

4.  Development and validation of a patient based measure of outcome in ocular melanoma.

Authors:  A J Foss; D L Lamping; S Schroter; J Hungerford
Journal:  Br J Ophthalmol       Date:  2000-04       Impact factor: 4.638

5.  Intraocular inflammation after proton beam irradiation for uveal melanoma.

Authors:  L Lumbroso; L Desjardins; C Levy; C Plancher; E Frau; F D'Hermies; P Schlienger; H Mammar; S Delacroix; C Nauraye; R Ferrand; C Desblancs; A Mazal; B Asselain
Journal:  Br J Ophthalmol       Date:  2001-11       Impact factor: 4.638

6.  Predictive factors for the development of rubeosis following proton beam radiotherapy for uveal melanoma.

Authors:  A J Foss; I Whelehan; J L Hungerford; D F Anderson; R D Errington; A Kacperek; M Restori; J Kongerud; M Sheen
Journal:  Br J Ophthalmol       Date:  1997-09       Impact factor: 4.638

7.  Neovascular glaucoma after proton beam therapy of choroidal melanoma: incidence and risk factors.

Authors:  Aline I Riechardt; Daniel Pilger; Dino Cordini; Ira Seibel; Enken Gundlach; Annette Hager; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-07-18       Impact factor: 3.117

8.  Is irradiation a justifiable treatment of choroidal melanoma? Analysis of published results.

Authors:  W A Manschot; R Van Strik
Journal:  Br J Ophthalmol       Date:  1987-05       Impact factor: 4.638

9.  Histopathologic findings in eyes treated with a ruthenium plaque for uveal melanoma.

Authors:  E Messmer; N Bornfeld; M Foerster; H Schilling; A Wessing
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.